Patent · US Active

Peptide clearing agents

US8846861B2 · kind B2 · utility

0Cited by
3References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2010
Grant dateSep 30, 2014
Priority date
Expiry dateOct 28, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/0202
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A peptide clearing agent is provided for clearance of a conjugate of an enzyme and a binding molecule which binds specifically at a target location from a non-target location in a subject. The peptide clearing agent binds the active site of the enzyme. The peptide also binds to the asialoglycoprotein receptor expressed by hepatic cells to facilitate clearance through the liver. The peptide may be glycosylated to facilitate clearance through the liver by binding to hepatic cells expressing an asialoglycoprotein receptor. Typically, the peptide prevents or inhibits enzyme activity upon binding to the enzyme and is not substantially modified by the enzyme activity. The peptide may be based upon the dipeptide amino-naphthoic acid (ANA)-glutamate (GIu) and may comprise the amino acid sequence serine (Ser)-Alanine (Ala)-amino-naphthoic acid (ANA)-glutamate (GIu). In such cases, the enzyme of interest is typically CPG2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.